Sarepta said on Monday that its late-stage study testing two gene-targeted therapies for Duchenne muscular dystrophy did not ...
A long-running confirmatory trial of two of Sarepta Therapeutics’ Duchenne muscular dystrophy drugs has missed its main goal.
Moonshot AI’s new Kimi K2 Thinking model has quickly captured the industry’s attention. Many observers are focused on its ...
Researchers say that the methods used to evaluate AI systems’ capabilities routinely oversell AI performance and lack ...
Despite struggles, the Jets battled through a tough road swing, snatching two hard-fought wins against Canadian rivals while ...
The hybrid model is emerging as the framework for trustworthy AI in test analytics. It retains traceability and supports ...
The critics said cherry-picked statistics don’t outweigh their lived experience. Miles has said that data-driven initiatives ...
Ophthalmologists discuss how advanced imaging, MIGS, and home monitoring are reshaping decision-making in complex glaucoma ...
Revolution Medicines, Inc. ( RVMD) Guggenheim Securities 2nd Annual Healthcare Innovation Conference November 11, 2025 9:00 AM EST All right. So we'll get started right away. So I'd like to welcome ...
The Government has a choice between outdated methods that hold back progress or compassionate, cutting-edge science that ...
FAMU football quarterback RJ Johnson III had one of his best performances in the Rattlers’ Week 12 victory over the Alabama A&M Bulldogs.
Mayo Clinic researchers have developed a new tool that can estimate a person's risk of developing memory and thinking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback